Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News GeneDx Holdings Corp WGS

Financial Services Healthcare
GeneDx Holdings Corp. is a genomics company. The Company is focused on delivering personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The Company's segments are GeneDx inclusive of Legacy GeneDx and Legacy Sema4. The GeneDx segment primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing... see more

Recent & Breaking News (NDAQ:WGS)

GeneDx Announces Partnership with Komodo Health to Expand Access to World's Largest Rare Disease Dataset

GlobeNewswire 2 days ago

GeneDx to Report First Quarter 2024 Financial Results on Monday, April 29, 2024

GlobeNewswire April 4, 2024

GeneDx to Present Data at the 2024 American College of Medical Genetics (ACMG) Annual Meeting Demonstrating Clinical Superiority of its Exome, Paving the Way for the Future of Genomics

GlobeNewswire March 14, 2024

GeneDx to Participate in 44th Annual Cowen Health Care Conference

GlobeNewswire February 26, 2024

GeneDx Reports Fourth Quarter and Full Year 2023 Financial Results and Issues Guidance for Full Year 2024

GlobeNewswire February 20, 2024

GeneDx to Report Fourth Quarter 2023 Financial Results on Tuesday, February 20, 2024 

GlobeNewswire February 1, 2024

GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire January 24, 2024

GeneDx Announces Preliminary 2023 Financial Results

GlobeNewswire January 8, 2024

GeneDx Presents New Data at the American Epilepsy Society Annual Meeting Demonstrating That Exome Sequencing Outperforms Multi-Gene Panels for Patients with Epilepsy

GlobeNewswire December 1, 2023

GeneDx to Participate in 6th Annual Evercore ISI HealthCONx Conference

GlobeNewswire November 28, 2023

GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire November 20, 2023

GeneDx Reports Third Quarter 2023 Financial Results and Business Highlights

GlobeNewswire October 30, 2023

GeneDx to Report Third Quarter 2023 Financial Results on Monday, October 30, 2023

GlobeNewswire October 9, 2023

GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire September 22, 2023

GeneDx Announces Evolution of Executive Leadership Team

GlobeNewswire September 11, 2023

GeneDx Announces Industry-Leading Accomplishment of 500,000 Clinical Exomes Sequenced

GlobeNewswire September 6, 2023

GeneDx Announces Data Demonstrating that Whole Exome and Genome Sequencing Report Fewer Variants of Uncertain Significance (VUS) than Multi-Gene Panel Testing Published in Genetics in Medicine

GlobeNewswire August 21, 2023

GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire August 8, 2023

GeneDx Reports Second Quarter 2023 Financial Results and Business Highlights

GlobeNewswire August 8, 2023

PacBio and GeneDx Launch Research Collaboration with the University of Washington to Study Long-Read Whole Genome Sequencing for Increased Diagnostic Yield in Neonatal Care

GlobeNewswire August 7, 2023